AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8578271
Drug: Propiverine 15
RxNorm normalized name: propiverine 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propiverine 15 mg/d
Trial: 8578271
Drug: Propiverine 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propiverine 30 mg/d
Trial: 8578271
Drug: Propiverine 45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propiverine 45 mg/d
Trial: 8578271
Drug: Propiverine 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propiverine 60 mg/d
Trial: 8578271
Drug: Propiverine (15,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propiverine (15, 30, 45, 60 mg/d)
Trial: 2084727
Drug: Homatropine hydrobromide
RxNorm normalized name: Homatropine Hydrobromide
DrugBank: Homatropine (DB11181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Homatropine hydrobromide (0.5% drops, two drops given twice spaced 15 minutes apart)
Trial: 26519
Drug: Nadolol 40
RxNorm normalized name: nadolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol 40 mg (20 mg twice daily) increased to a maximum of 560 mg daily
Trial: 9137021
Drug: Needle injections
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle injections
Trial: 28577267
Drug: Active music
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active music therapy (AMT)
Trial: 25636304
Drug: Dextromethorphan (maximal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (maximal dose 90 mg/day)
Trial: 23896810
Drug: More study
RxNorm normalized name: polyurethane-35 (not more than MPA.S at 40 %)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: More study sites, fewer university or Veterans Affairs treatment settings, lower percentage of patients assigned to receive placebo
Trial: 21563510
Drug: Cognitive-behavior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavior therapy and acupoint stimulation
Trial: 19304469
Drug: Ointment with
RxNorm normalized name: OINTMENT WITH APPLICATOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ointment with high dosed herbal ingredients (verum)
Trial: 19304469
Drug: Placebo ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ointment (control)
Trial: 16409423
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg once daily continuously
Trial: 16409423
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg once daily on-demand
Trial: 16409423
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg twice daily continuously
Trial: 15064010
Drug: Amifostine 200
RxNorm normalized name: Amifostine
DrugBank: Amifostine (DB01143)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amifostine 200 mg/m2
Trial: 15064010
Drug: Amifostine 340
RxNorm normalized name: Amifostine
DrugBank: Amifostine (DB01143)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amifostine 340 mg/m2
Trial: 15064010
Drug: Amifostine (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amifostine (both doses)
Trial: 2229525
Drug: Terbinafine 1%
RxNorm normalized name: Terbinafine 1% Topical application Gel/Jelly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine 1% cream
Trial: 24527444
Drug: Propofol anesthesia
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol anesthesia (infusion with remifentanil)
Trial: 22699673
Drug: 5% EMLA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% EMLA anesthetic cream
Trial: 20357176
Drug: GnRH doses
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH doses of 0, 2.5, 10, 25, 250, and 750 ng
Trial: 20357176
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone clamp
Trial: 12186515
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin K (1 mg, administered orally)
Trial: 12186515
Drug: Subcutaneous vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous vitamin K (1 mg, administered subcutaneously)
Trial: 10329812
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 88 micrograms twice daily
Trial: 10329812
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 220 micrograms twice daily
Trial: 10329812
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate 168 micrograms twice daily
Trial: 10329812
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate 336 micrograms twice daily
Trial: 29101333
Drug: delta‐9‐THC (10 mg)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: delta‐9‐THC (10 mg)
Trial: 26611777
Drug: Single intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single intravenous infusion of 1500 mg of dalbavancin
Trial: 26611777
Drug: 2-dose regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-dose regimen of dalbavancin (1000 mg IV on day 1 followed by 500 mg IV one week later)
Trial: 26611777
Drug: 2-dose regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-dose regimen of dalbavancin
Trial: 26611777
Drug: Single intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single intravenous infusion of 1500 mg of dalbavancin in MRSA patients
Trial: 26611777
Drug: 2-dose regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-dose regimen of dalbavancin in MRSA patients
Trial: 22167662
Drug: Bevacizumab 5
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab 5 mg/kg with FOLFIRI
Trial: 22167662
Drug: Bevacizumab 10
RxNorm normalized name: bevacizumab 100 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab 10 mg/kg with FOLFIRI
Trial: 20141248
Drug: Carriers of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carriers of the DRD4-L allele
Trial: 12227681
Drug: Carvedilol (25-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (25-50 mg o.d. orally for 4 months)
Trial: 12227681
Drug: Nifedipine (as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (as comparator antihypertensive drug)
Trial: 3881561
Drug: Chemotherapy (CMFP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (CMFP and CMFPT groups combined)
Trial: 20655559
Drug: Flomoxef 1
RxNorm normalized name: flomoxef
DrugBank: Flomoxef (DB11935)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flomoxef 1 g administered immediately before surgery
Trial: 20655559
Drug: Flomoxef 1
RxNorm normalized name: flomoxef
DrugBank: Flomoxef (DB11935)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flomoxef 1 g administered twice daily for a total of 4 days from the day of surgery to postoperative day 3
Trial: 18256922
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist ovulation trigger
Trial: 17166989
Drug: Montelukast, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast, 10 mg taken in the evening
Trial: 12715418
Drug: Low calorie
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low calorie diet (1000 kcal below daily energy requirement, 1200-1500 kcal per day, 5-6 meals a day)
Trial: 10766181
Drug: murine IgG2a
RxNorm normalized name: Murine Ear
FDA approved: no
EMA approved: no
PMDA approved: no
Description: murine IgG2a mAb 17‐1A (500mg single infusion followed by 100mg four times every 4 weeks)
Trial: 9149186
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg o.m. + Amoxicillin 1 g t.i.d. + Metronidazole 250 mg t.i.d. (first 2 weeks)
Trial: 9149186
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg o.m. + Amoxicillin 1 g t.i.d. + Metronidazole 250 mg t.i.d. (last 2 weeks)
Trial: 8381089
Drug: Inhaled nedocromil
RxNorm normalized name: nedocromil Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nedocromil sodium (Tilade)
Trial: 3284943
Drug: Intravenous APSAC
RxNorm normalized name: APSAC
DrugBank: Anistreplase (DB00029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous APSAC
Trial: 3315592
Drug: Reperfused patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reperfused patients (either agent)
Trial: 3315592
Drug: Non-reperfused patients
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-reperfused patients (either agent)
Trial: 3315592
Drug: Intracoronary streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary streptokinase and intravenous APSAC
Trial: 31361318
Drug: HNF1β SNP
RxNorm normalized name: SNP-ACTH (1-39)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HNF1β SNP rs752010 G > A
Trial: 30053811
Drug: DENV-specific immunoglobulin
RxNorm normalized name: immunoglobulin A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DENV-specific immunoglobulin G (IgG) antibodies testing using Anti-dengue IgG ELISA
Trial: 27433065
Drug: Curcumin gel
DrugBank: Curcumin sulfate (DB14635)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin gel
Trial: 25126527
Drug: Triamcinolone Acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone Acetonide gel
Trial: 17503877
Drug: Nutritional supplements
RxNorm normalized name: nutritional supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplements (vitamin C, vitamin E, flavonoids, L-carnitine)
Trial: 17503877
Drug: Nutritional supplements
RxNorm normalized name: nutritional supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplements (various including antioxidants and amino acids)
Trial: 30381282
Drug: Nutritional supplements
RxNorm normalized name: nutritional supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplements
Trial: 15857429
Drug: Topiramate (TPM)
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate (TPM) 200 mg/day added to carbamazepine (CBZ)
Trial: 12165828
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg ondansetron (Group A, n = 29)
Trial: 12165828
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg tropisetron (Group B, n = 31)
Trial: 3389978
Drug: Placental albumin
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placental albumin (1.5 g/kg)
Trial: 3389978
Drug: Plasmatic albumin
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasmatic albumin (1.5 g/kg)
Trial: 31436310
Drug: Patient-controlled sedation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled sedation (PCS) with propofol administered by a bedside nurse anaesthetist
Trial: 31436310
Drug: Midazolam sedation
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam sedation administered by the endoscopic team
Trial: 24593291
Drug: Chinese five-element
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese five-element music therapy
Trial: 19118825
Drug: Acupuncture (Ac)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture (Ac) during IVF treatment
Trial: 16728231
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment (controls)
Trial: 15226097
Drug: Coagulation Inhibitor
RxNorm normalized name: Protein C (coagulation inhibitor)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coagulation Inhibitor Potential (CIP)
Trial: 9469625
Drug: Argatroban (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argatroban (60 mg/d for the first 2 days, then 10 mg twice daily for 5 days)
Trial: 9272101
Drug: hGH at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hGH at a weekly dosage of 0.5 IU/kg
Trial: 9272101
Drug: hGH at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hGH at a weekly dosage of 1.0 IU/kg
Trial: 2658450
Drug: Combined administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined administration of 0.5 IU/kg/week hGH and a small amount of anabolic steroid
Trial: 31466474
Drug: Nonsteroidal anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal anti-inflammatory drugs (NSAIDs) including aspirin, naproxen, diclofenac, ibuprofen, and selective cyclooxygenase 2 inhibitors such as celecoxib.
Trial: 23406026
Drug: Neurostimulation plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neurostimulation plus medical therapy
Trial: 18842671
Drug: High bicarbonate
RxNorm normalized name: Potassium Bicarbonate
DrugBank: Potassium bicarbonate (DB11098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High bicarbonate concentration (35 mmol/l)
Trial: 18842671
Drug: High calcium
RxNorm normalized name: Nutritional Supplement Oral Liquid [ENSURE HIGH CALCIUM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High calcium concentration (1.50 mmol/l)
Trial: 7999486
Drug: ephedrine 1
RxNorm normalized name: ephedrine 1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ephedrine 1 mg min‐1 (group E1: n = 10)
Trial: 7999486
Drug: ephedrine 2
RxNorm normalized name: ephedrine 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ephedrine 2 mg min‐1 (group E2: n = 9)
Trial: 7999486
Drug: phenylephrine 10
RxNorm normalized name: phenylephrine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: phenylephrine 10 micrograms min‐1 with bolus doses of 20 micrograms
Trial: 7999486
Drug: ephedrine 1
RxNorm normalized name: ephedrine 1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ephedrine 1 or 2 mg min‐1 with bolus doses of 6 mg
Trial: 3873511
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose trimethoprim-sulfamethoxazole
Trial: 30962423
Drug: Cortisol administration
RxNorm normalized name: cortisol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol administration after extinction training (n = 25)
Trial: 30962423
Drug: Placebo administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administration after extinction training (n = 25)
Trial: 29197407
Drug: Low tidal
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low tidal volume (LTV) ventilation: 5 breaths/minute with a tidal volume of 3 mL/kg and positive end-expiratory pressure of 5 cmH2O
Trial: 16472987
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg clindamycin
Trial: 16472987
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g phenethicillin
Trial: 10728957
Drug: Oral glycoprotein
RxNorm normalized name: Zaire ebolavirus envelope glycoprotein Injection [Ervebo]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glycoprotein IIb‐IIIa inhibitor orbofiban
Trial: 1539881
Drug: Buffered lidocaine
RxNorm normalized name: buffered lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buffered lidocaine solutions prepared seven days, one day, and just before use
Trial: 3725653
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (ampicillin and chloramphenicol)
Trial: 29633302
Drug: Efavirenz tablets
RxNorm normalized name: Efavirenz Tablets
DrugBank: Efavirenz (DB00625)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Efavirenz tablets (test product) in females
Trial: 29633302
Drug: Efavirenz tablets
RxNorm normalized name: Efavirenz Tablets
DrugBank: Efavirenz (DB00625)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Efavirenz tablets (test product) in males
Trial: 29633302
Drug: Efavirenz tablets
RxNorm normalized name: Efavirenz Tablets
DrugBank: Efavirenz (DB00625)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Efavirenz tablets (test product) in females (pivotal study)
Trial: 29633302
Drug: Efavirenz tablets
RxNorm normalized name: Efavirenz Tablets
DrugBank: Efavirenz (DB00625)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Efavirenz tablets (test product) in males (pivotal study)
Trial: 27847634
Drug: Intravitreal aflibercept
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal aflibercept injection (IAI) 2 mg every 8 weeks (2q8)
Trial: 22487001
Drug: Parnaparin 8500
RxNorm normalized name: parnaparin
DrugBank: Parnaparin (DB09260)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parnaparin 8500 UI once daily for 10 days followed by placebo for 20 days (group A)
Trial: 22487001
Drug: Parnaparin 8500
RxNorm normalized name: parnaparin
DrugBank: Parnaparin (DB09260)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parnaparin 8500 UI once daily for 10 days followed by 6400 UI once daily for 20 days (group B)
Trial: 22487001
Drug: Parnaparin 4250
RxNorm normalized name: parnaparin
DrugBank: Parnaparin (DB09260)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parnaparin 4250 UI once daily for 30 days (group C)
Trial: 20517641
Drug: Buspirone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (0.5 mg/kg/day)
Trial: 20517641
Drug: Methylphenidate (0.3-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (0.3-1 mg/kg/day)
Trial: 15127961
Drug: Granisetron (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron (10 microg/kg or 1 mg)
Trial: 7646913
Drug: Subcapsular orchiectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcapsular orchiectomy plus oral hydrocortisone and bromocriptine (arm 3)
Trial: 2676529
Drug: Oral controlled-release
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral controlled-release morphine (30 mg)
Trial: 25483694
Drug: Bivalent Staphylococcus
RxNorm normalized name: Staphylococcus simulans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalent Staphylococcus aureus glycoconjugated vaccine (2 doses)
Trial: 19168553
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose MDMA (1.0 mg/kg)
Trial: 19168553
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose MDMA (1.6 mg/kg)
Trial: 11833048
Drug: 75 g
RxNorm normalized name: Zosyn 3.375 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 g sucrose with a moderate fat load
Trial: 11833048
Drug: 75 g
RxNorm normalized name: Zosyn 3.375 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 g glucose with a moderate fat load
Trial: 10084100
Drug: 30 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 micrograms kg-1 morphine
Trial: 29029896
Drug: Clemastine fumarate
RxNorm normalized name: Clemastine Fumarate
DrugBank: Clemastine (DB00283)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clemastine fumarate (5·36 mg orally twice daily) for 90 days
Trial: 29029896
Drug: Clemastine fumarate
RxNorm normalized name: Clemastine Fumarate
DrugBank: Clemastine (DB00283)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clemastine fumarate (5·36 mg orally twice daily) for 60 days
Trial: 23415431
Drug: Hazelnut-enriched diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hazelnut-enriched diet (4 weeks; hazelnut contributing 18%-20% of total daily energy intake)
Trial: 21240901
Drug: Vitamin D(3)
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D(3) 15 μg daily
Trial: 15355147
Drug: Similarity of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Similarity of solution tool
Trial: 9481031
Drug: Cod liver
RxNorm normalized name: Cod Liver Oil
DrugBank: Cod liver oil (DB11321)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cod liver oil (10 mL daily)
Trial: 9481031
Drug: Corn oil
RxNorm normalized name: Corn Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn oil (10 mL daily)
Trial: 7817456
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A and megadose multivitamins in combination with intravesical BCG
Trial: 6187790
Drug: Compound 48/80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound 48/80
Trial: 2918185
Drug: Antigen vs
RxNorm normalized name: Blood group antigen VS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antigen vs Compound 48/80
Trial: 17361529
Drug: Conventional Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Western medicine plus Xin'anning Nasal Drop (XAND)